Exact Mass: 539.1825
Exact Mass Matches: 539.1825
Found 326 metabolites which its exact mass value is equals to given mass value 539.1825
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pipracil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Phytochelatin 2
A phytochelatin that is a pentapeptide consisting of 2 units of gamma-Glu-Cys, with a glycyl unit at the C-terminus.
Pulcherosine
Pulcherosine is found in herbs and spices. Pulcherosine is found in the primary cell walls of tomato cell cultures. Found in the primary cell walls of tomato cell cultures
Encorafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Encorafenib (LGX818) is a highly potent BRAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing BRAFV600E (EC50=4 nM).
7beta-Acetoxy-6beta-benzoyloxy-3alpha-(3,4,5-trimethoxycinnamoyloxy)tropane
(gamma-Glu-Cys)2-Gly|Cadystin (gammaEC)2G|gammaGlu-Cys-gammaGlu-Cys-Gly|H-(gamma-Glu-Cys)2-Gly-OH|H-2-Gly-OH|H-gamma-L-Glu-L-Cys-gamma-L-Glu-L-Cys-Gly-OH (cadystin B <2>)|PC2
Asn Tyr Glu Asp
Asp Lys Tyr Asp
Cys Cys Glu Trp
Cys Cys Trp Glu
Cys Asp Phe Arg
Cys Asp Arg Phe
Cys Glu Cys Trp
Cys Glu Trp Cys
Cys Phe Asp Arg
Cys Phe Arg Asp
Cys Met Met Arg
Cys Met Arg Met
Cys Met Thr Trp
Cys Met Trp Thr
Cys Arg Asp Phe
Cys Arg Phe Asp
Cys Arg Met Met
Cys Thr Met Trp
Cys Thr Trp Met
Cys Trp Cys Glu
Cys Trp Glu Cys
Cys Trp Met Thr
Cys Trp Thr Met
Asp Cys Phe Arg
Asp Cys Arg Phe
Asp Asp Lys Tyr
Asp Asp Gln Tyr
Asp Asp Tyr Lys
Asp Asp Tyr Gln
Asp Glu Asn Tyr
Asp Glu Tyr Asn
Asp Phe Cys Arg
Asp Phe Met Gln
Asp Phe Gln Met
Asp Phe Arg Cys
Asp Gly Trp Tyr
Asp Gly Tyr Trp
Asp Lys Asp Tyr
Asp Met Phe Gln
Asp Met Gln Phe
Asp Asn Glu Tyr
Asp Asn Tyr Glu
Asp Gln Asp Tyr
Asp Gln Phe Met
Asp Gln Met Phe
Asp Gln Tyr Asp
Asp Arg Cys Phe
Asp Arg Phe Cys
Asp Trp Gly Tyr
Asp Trp Tyr Gly
Asp Tyr Asp Lys
Asp Tyr Asp Gln
Asp Tyr Glu Asn
Asp Tyr Gly Trp
Asp Tyr Lys Asp
Asp Tyr Asn Glu
Asp Tyr Gln Asp
Asp Tyr Trp Gly
Glu Cys Cys Trp
Glu Cys Trp Cys
Glu Asp Asn Tyr
Glu Asp Tyr Asn
Glu Phe Met Asn
Glu Phe Asn Met
Glu Met Phe Asn
Glu Met Asn Phe
Glu Asn Asp Tyr
Glu Asn Phe Met
Glu Asn Met Phe
Glu Asn Tyr Asp
Glu Gln Thr Tyr
Glu Gln Tyr Thr
Glu Thr Gln Tyr
Glu Thr Tyr Gln
Glu Trp Cys Cys
Glu Tyr Asp Asn
Glu Tyr Asn Asp
Glu Tyr Gln Thr
Glu Tyr Thr Gln
Phe Cys Asp Arg
Phe Cys Arg Asp
Phe Asp Cys Arg
Phe Asp Met Gln
Phe Asp Gln Met
Phe Asp Arg Cys
Phe Glu Met Asn
Phe Glu Asn Met
Phe Gly Met Trp
Phe Gly Trp Met
Phe Met Asp Gln
Phe Met Glu Asn
Phe Met Gly Trp
Phe Met Asn Glu
Phe Met Gln Asp
Phe Met Trp Gly
Phe Asn Glu Met
Phe Asn Met Glu
Phe Gln Asp Met
Phe Gln Met Asp
Phe Arg Cys Asp
Phe Arg Asp Cys
Phe Trp Gly Met
Phe Trp Met Gly
Gly Asp Trp Tyr
Gly Asp Tyr Trp
Gly Phe Met Trp
Gly Phe Trp Met
Gly Met Phe Trp
Gly Met Trp Phe
Gly Trp Asp Tyr
Gly Trp Phe Met
Gly Trp Met Phe
Gly Trp Tyr Asp
Gly Tyr Asp Trp
Gly Tyr Trp Asp
Lys Asp Asp Tyr
Lys Asp Tyr Asp
Lys Met Met Met
Lys Tyr Asp Asp
Met Cys Met Arg
Met Cys Arg Met
Met Cys Thr Trp
Met Cys Trp Thr
Met Asp Phe Gln
Met Asp Gln Phe
Met Glu Phe Asn
Met Glu Asn Phe
Met Phe Asp Gln
Met Phe Glu Asn
Met Phe Gly Trp
Met Phe Asn Glu
Met Phe Gln Asp
Met Phe Trp Gly
Met Gly Phe Trp
Met Gly Trp Phe
Met Lys Met Met
Met Met Cys Arg
Met Met Lys Met
Met Met Met Lys
Met Met Met Gln
Met Met Gln Met
Met Met Arg Cys
Met Asn Glu Phe
Met Asn Phe Glu
Met Gln Asp Phe
Met Gln Phe Asp
Met Gln Met Met
Met Arg Cys Met
Met Arg Met Cys
Met Thr Cys Trp
Met Thr Trp Cys
Met Trp Cys Thr
Met Trp Phe Gly
Met Trp Gly Phe
Met Trp Thr Cys
Asn Asp Glu Tyr
Asn Asp Tyr Glu
Asn Glu Asp Tyr
Asn Glu Phe Met
Asn Glu Met Phe
Asn Glu Tyr Asp
Asn Phe Glu Met
Asn Phe Met Glu
Asn Met Glu Phe
Asn Met Phe Glu
Asn Tyr Asp Glu
Gln Asp Asp Tyr
Gln Asp Phe Met
Gln Asp Met Phe
Gln Asp Tyr Asp
Gln Glu Thr Tyr
Gln Glu Tyr Thr
Gln Phe Asp Met
Gln Phe Met Asp
Gln Met Asp Phe
Gln Met Phe Asp
Gln Met Met Met
Gln Thr Glu Tyr
Gln Thr Tyr Glu
Gln Tyr Asp Asp
Gln Tyr Glu Thr
Gln Tyr Thr Glu
Arg Cys Asp Phe
Arg Cys Phe Asp
Arg Cys Met Met
Arg Asp Cys Phe
Arg Asp Phe Cys
Arg Phe Cys Asp
Arg Phe Asp Cys
Arg Met Cys Met
Arg Met Met Cys
Thr Cys Met Trp
Thr Cys Trp Met
Thr Glu Gln Tyr
Thr Glu Tyr Gln
Thr Met Cys Trp
Thr Met Trp Cys
Thr Gln Glu Tyr
Thr Gln Tyr Glu
Thr Trp Cys Met
Thr Trp Met Cys
Thr Tyr Glu Gln
Thr Tyr Gln Glu
Trp Cys Cys Glu
Trp Cys Glu Cys
Trp Cys Met Thr
Trp Cys Thr Met
Trp Asp Gly Tyr
Trp Asp Tyr Gly
Trp Glu Cys Cys
Trp Phe Gly Met
Trp Phe Met Gly
Trp Gly Asp Tyr
Trp Gly Phe Met
Trp Gly Met Phe
Trp Gly Tyr Asp
Trp Met Cys Thr
Trp Met Phe Gly
Trp Met Gly Phe
Trp Met Thr Cys
Trp Thr Cys Met
Trp Thr Met Cys
Trp Tyr Asp Gly
Trp Tyr Gly Asp
Tyr Asp Asp Lys
Tyr Asp Asp Gln
Tyr Asp Glu Asn
Tyr Asp Gly Trp
Tyr Asp Lys Asp
Tyr Asp Asn Glu
Tyr Asp Gln Asp
Tyr Asp Trp Gly
Tyr Glu Asp Asn
Tyr Glu Asn Asp
Tyr Glu Gln Thr
Tyr Glu Thr Gln
Tyr Gly Asp Trp
Tyr Gly Trp Asp
Tyr Lys Asp Asp
Tyr Asn Asp Glu
Tyr Asn Glu Asp
Tyr Gln Asp Asp
Tyr Gln Glu Thr
Tyr Gln Thr Glu
Tyr Thr Glu Gln
Tyr Thr Gln Glu
Tyr Trp Asp Gly
Tyr Trp Gly Asp
Pulcherosine
(3AR,8AR)-N,N,2,2-TETRAMETHYL-4,4,8,8-TETRAPHENYLTETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-AMINE
4-[(2,4-Dimethoxyphenyl)(Fmoc-amino)methyl]phenoxyacetic Acid
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid
choline magnesium trisalicylate
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents
(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a3,4-a]dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine
6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide, 4-(4-chlorophenyl)-2,3,9-trimethyl-N-(3-(4-methyl-1-piperazinyl)propyl)-, (6S)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
N-[(1,1-Dimethylethoxy)carbonyl]-L-tryptophan-2-[[[2-[(2-ethylphenyl)amino]-2-oxoethyl]thio]carbonyl]hydrazide
5-[2-[3-(4-Fluorophenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-oxoethoxy]-2-(phenylmethyl)-3,4-dihydroisoquinolin-1-one
Encorafenib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EC - B-raf serine-threonine kinase (braf) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Encorafenib (LGX818) is a highly potent BRAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing BRAFV600E (EC50=4 nM).
N-[5,6-bis[(2,3-dihydroxybenzoyl)amino]hexyl]-2,3-dihydroxybenzamide
Lys-Met-Met-Met
A tetrapeptide composed of L-lysine and three L-methionine units joined in sequence by peptide linkages.
N-[(2R)-1-[[[[2-(2-ethylanilino)-2-oxoethyl]thio]-oxomethyl]hydrazo]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamic acid tert-butyl ester
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[(2S,4aR,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2S,4aS,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(2-methoxyphenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-pyridinecarboxamide
N-[(2R,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2R,4aS,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
(3S)-2-tert-butylsulfinyl-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3R)-2-tert-butylsulfinyl-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(3-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(2S,4aR,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2R,4aR,12aR)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
N-[(2S,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-chlorobenzamide
4,7-DI(4-Butoxyphenyl)-6-(2-methoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
Piperacillin Sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic